The Next Big Deal: Market Outlook for 2021 and Beyond

12:45 PM - 1:30 PM (EDT), Tuesday, June 15, 2021
Search General Info
Search Education
Search Partnering Companies

Dealmakers adjusted to the new landscape of remote work and navigating a global health crisis in 2020. These challenges created opportunities to examine new approaches in M&A, licensing, and collaborations. How are companies making decisions on acquisitions and valuation? What is on the horizon for the second half of 2021? Top-performing industry deal-makers will explore the impact market forces will have on pharmaceutical and biotech companies as they strive to make the next big deal. 

Sponsored By
Moderator
photo
Partner & Co-Chair, Life Sciences Group; Chair, Licensing & Strategic Alliances Practice
Foley Hoag LLP
Speakers
photo
Partner & Co-Chair, Life Sciences Group; Chair, Licensing & Strategic Alliances Practice
Foley Hoag LLP
photo
Vice President & Head New Business Development
Bayer AG
photo
Senior Vice President and Head of Business Development and Licensing
Merck
photo
Vice President, Janssen Business Development, Immunology
Janssen